Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
The Income Investor's Dream Team: 7 Sturdy Dividend Stocks Yielding 6%
06:37am, Tuesday, 04'th Jun 2024
The most obvious reason investors should buy high-yield dividend stocks is that they provide income. Non-dividend stocks do not provide income and only provide cash when sold.
7 High-Yield Dividend Stocks That Work While You Sleep
06:00am, Tuesday, 04'th Jun 2024
Although seemingly most of the celebrated ideas on financial publications center on high-growth plays, investors should spare some thought toward high-yield dividend stocks. In particular, I'm referri
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer
05:29am, Tuesday, 04'th Jun 2024
Sales of Pfizer's COVID-19-related products are down sharply, and so is the stock price. Pfizer stock has fallen about 24% over the past year.
Pfizer CEO: Cancer drugs will be our next big contribution to the world
11:42am, Monday, 03'rd Jun 2024
Pfizer CEO Albert Bourla joins 'Squawk on the Street' to discuss the company's recent lung cancer drug data, how the drug could change the company's revenues, and more.
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
10:00am, Monday, 03'rd Jun 2024
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the Gold
Retirement Roadblocks: 7 Stocks to Avoid as You Near the Finish Line
08:38am, Monday, 03'rd Jun 2024
As you approach retirement, it's crucial to carefully consider your investment portfolio and make strategic decisions to safeguard your financial future. While some stocks may seem attractive, certain
Earn An 'Embarrassing' Amount Of Cash Flow From These Contrarian Picks
08:10am, Monday, 03'rd Jun 2024
Amazon CEO Andy Jassy highlights key traits for success in a career professional, including working hard, being can-do, and following through on commitments. There are different paths to success, and
7 Overlooked Stocks That Belong in Every Portfolio
06:00am, Monday, 03'rd Jun 2024
The financial media does its best to keep you informed about what's happening in the market. However, this has the effect of giving significant attention to a handful of leaders or laggards.
4 Fortune 500 Industry Leaders Boast Ideal June Dividends
09:02am, Sunday, 02'nd Jun 2024
The 50 largest companies on the Fortune 500 list accounted for nearly half of the total revenue and earnings. Four stocks from the Fortune 500 list were identified as ideal for first-time investors du
3 Discounted Stocks Poised for a Major Upswing
07:22am, Sunday, 02'nd Jun 2024
Due to their robust financial and strategic approaches, these three equities are all seeing notable progress in their respective industries. Recent financial results for the first one show robust reve
Blue-Chip Blunders: 7 Stocks to Sell as Management Missteps Mount
06:30am, Sunday, 02'nd Jun 2024
While macro-related issues are a factor, it's company-specific issues that play a more significant role in causing shares from top companies to become blue-chip stocks to sell. Some company-specific i
OSAKA, Japan & CAMBRIDGE, Mass. & NEW YORK--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) and Pfizer (NYSE: PFE) today announced that the German Hodgkin Study Group (GHSG) will present positive results
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced detailed overall survival (OS) results from the Phase 3 ECHELON-3 study of ADCETRIS® (brentuximab vedotin) in combination with lenal
Is Pfizer the Best Dividend Stock for You?
03:00am, Saturday, 01'st Jun 2024
Pfizer's COVID-19 vaccine revenue is drying up. But the company's push into oncology should reignite growth.
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
07:10pm, Friday, 31'st May 2024
Pfizer expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 after most patients treated for a form of lung cancer had no disease progression after five years.
